How Liquid Biopsies Can Complement Tissue Biopsies
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx...
Category: Research
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx...
Numerous studies have shown that individuals with cancer fare worse than the general population if they contract COVID-19, with...
Back for the month of February is our regular staple, Editors’ Picks, which features the “must read” articles that...
As infections from SARS-CoV-2 began to rapidly spread across the United States in early 2020, many nonessential medical procedures, including cancer screenings, were...
On December 31, 2019, the first cases of “a pneumonia of unknown cause”—now known to be COVID-19—were reported in China, and the initial confirmed...
The first AACR virtual meeting of 2021, held Jan. 11-12, focused on the tumor microenvironment, the complex framework of...
Racial/ethnic inequities in cancer are well documented. Not only are Black Americans more likely to die of cancer than white Americans, but Black and Hispanic individuals are...
Editor’s note: Thursday, Feb. 4, marks World Cancer Day, an annual initiative led by the Union for International Cancer...
Guest Post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today Clearly, cancers that have metastasized, or spread, to many different...
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...